Werewolf Therapeutics, Inc. revenue breakdown overview

Werewolf Therapeutics, Inc. revenue for the last year amounted to 19.94 M USD, the most of which — 19.94 M USD — came from its highest performing source at the moment, Cancer Therapeutics, the year earlier bringing 16.40 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Werewolf Therapeutics, Inc. 19.94 M USD, and the year before that — 16.40 M USD.